(Date:11/6/2009)...alif., Nov. 6 ,, 3...fer of Qutenza(TM) E.U. Marketing Authorization to...ogress in commercial readiness activities Expande...ctor, Marketing; and Director, Commercial Operatio...ctor and Audit Committee chairman , Upcomin...
(Date:11/6/2009)...if., Nov. 6 Intarcia Therapeutics,...A 650 (DUROS® continuous delivery of exenatid... the Ninth Annual Diabetes Technology Meeting in S....com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,, C...TCA 650 Lowers Plasma Glucose, HbA1c and Reduces W...
(Date:11/5/2009)..., Md., Nov. 5 GenVec, In...results for the third quarter ended September 30, ...$0.04 per share) for the three months ended Septem...n ($0.08 per share) in the comparable quarter of 2... GenVec,s net loss was $14.1 million ($0.15 per sh...
(Date:11/5/2009)...ov. 5 Imagenetix, Inc. (...lliam Spencer, President and CEO of Imagenetix, wi...nual LD MICRO Conference on Thursday, December 3rd...s. ,, About LD MICRO ,, LD MICRO is a by-inv...ng undervalued companies in the micro-cap space. S...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2...cals,Inc. (Nasdaq: ARNA ) announced today that th...oFin Rodman & Renshaw 9th Annual Healthcare,Confer...e (9:20 a.m.,Pacific Time) at the New York Palace ... Vice President, Finance and Chief Financial Offic...f the company and its clinical,development and dis...
... German . , The automatic molecular assembly an...h start as random mixtures, demonstrates a fundame...on is activated by instructions which are built-in...bit active selection: those in incorrect positions...The molecular-level observation of such self-selec...
...at Purdue University, working with the U.S. Air Fo...t enough to survive the harsh conditions inside je...se to failing and prevent breakdowns. , The devic...as "micro electromechanical systems," or MEMS, whi...ical components on a microscopic scale. , "The ME...
Other Biology Technology:Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 3Evolution in the nanoworld 2Evolution in the nanoworld 3Purdue creating wireless sensors to monitor bearings in jet engines 2Purdue creating wireless sensors to monitor bearings in jet engines 3HV Mini 5 (230V / 50Hz) from Thermo Scientific
Immulon 1 B 1x12 Strip from Thermo Scientific
Peptides from Thermo Scientific
RapidStak 2 (requires 4 staks, not included) from Thermo Scientific
Biology Products: